Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Magnetic Resonance in Medicine|February 26, 2021
Whole-brain quantitative CEST MRI at 7T using parallel transmission methods and correctionAndrzej Liebert, Katharina Tkotz, Jürgen Herrler, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 14, 2021
Longitudinal Sodium MRI of Multiple Sclerosis Lesions: Is there Added Value of Sodium Inversion Recovery MRIAngelika B Mennecke, Armin M Nagel, Konstantin Huhn, et al.
Magnetic Resonance Imaging|August 22, 2019
High resolution time-of-flight MR-angiography at 7 T exploiting VERSE saturation, compressed sensing and segmentationChristian R Meixner, Patrick Liebig, Peter Speier, et al.
Blood|December 6, 2003
Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2Andreas Burchert, Dali Cai, Lorenz C Hofbauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancerMartin R Weihrauch, Sascha Ansén, Elke Jurkiewicz, et al.
Magnetic Resonance Imaging|December 15, 2021
Direct imaging of white matter ultrashort T2∗ components at 7 TeslaMax Müller, Nico Egger, Stefan Sommer, et al.
Neuroimage|March 24, 2021
Brain tissues have single-voxel signatures in multi-spectral MRIAlexander German, Angelika Mennecke, Jan Martin, et al.
Blood|October 24, 2002
Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemiaAndreas Burchert, Stefan Wölfl, Manuel Schmidt, et al.
Magnetic Resonance in Medicine|November 15, 2022
DeepCEST 7 T: Fast and homogeneous mapping of 7 T CEST MRI parameters and their uncertainty quantificationLeonie Hunger, Junaid R Rajput, Kiril Klein, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2014
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumoursMartin R Weihrauch, Heike Richly, Michael S von Bergwelt-Baildon, et al.
Pageof 9